Hangzhou, China · Founded 2013 · Privately Held (backing)
Developer of nucleic acid therapeutics designed to advance biomedical science and improve human health outcomes. Haichang Biotech is based in Hangzhou, China and was founded in 2013. Its last reported valuation was $384 million in Dec 2024. It has raised $211 million.
Last reported valuation
$383.7M
Oct 2026
Priced at
—
Total raised
$210.7M
Last round
—
Cap table — not yet on record
Haichang Biotech's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Haichang Biotech with a free account
·The complete investor list: 19 names
·Watch Haichang Biotech: the Monday email on marks, rounds and moves
